期刊文献+

P53基因质粒联合反义c-myc基因质粒对人膀胱癌细胞T24生长的影响 被引量:1

Influence of P53 Gene Plasmid Combined with Antisense c - myc Gene Plasmid on Growth of Human bladder Cancer Cell T24
下载PDF
导出
摘要 目的 探讨P53基因质粒联合反义c-myc基因质粒对人膀胱癌细胞T24增殖及凋亡的作用。方法 将可在真核细胞表达P53蛋白的质粒pCEP4P53和表达反义c-myc基因的质粒pGEP4ASCMHC以染试剂Fu-GENE6为介导,同时转染到入膀胱癌细胞T24中,经MTT检测、软琼脂集落生长、琼脂糖电泳等方法分析实验结果。结果P53基因质粒联合反义c-myc基因质粒较单一基因质粒能更显著地抑制癌细胞的增长,并能引起癌细胞的凋亡;FuGENE6有助于提高质粒DNA的转染效率。结论 pCEP4P53基因质粒和反义c-myc基因质粒pCEP4AS-CMH的协同作用,大大地促进了肿瘤细胞的凋亡,为人膀胱癌的基因治疗提供了新途径。 Objective To study the effect of P53 gene plasmid combined with antisense c - myc gene plasmid on the proliferation and apoptosis of human bladder cancer cell T24. Methods The plasmid pCEP4P53 expressing human p53 protein and the plasmid pCEP4ASCMH expressing human antisense c - myc gene in eukaryocyte were co - transfected to human bladder cancer cell T24 strain using FuGENE6 as a media, and the results were analyzed by MTT method, cell colony - forming test in soft agar medium and agarose gel electrophoresis. Results The combined plasmid pCEP4P53/pCEP4ASCMH inhibited the proliferation and induced the apoptosis of human bladder cancer cell T24 more significantly than plasmid pCEP4P53 or pCEP4AS-CMH alone, the FuGENE6 promoted the transfection of plasmid DNA. Conclusion The plasmid pCEP4P53 combined with plasmid pCEP4ASCMH promoted the apoptosis of human bladder cancer cell T24 significantly. The study provides a new route for the gene therapy of human bladder cancer.
出处 《中国生物制品学杂志》 CAS CSCD 2002年第4期205-208,共4页 Chinese Journal of Biologicals
关键词 P53基因质粒 反义c-myc基因质粒 人膀胱癌细胞T24 生长 癌细胞凋亡 协同作用 P53 gene Antisense c - myc Bladder cancer cell Apoptosis
  • 相关文献

参考文献6

  • 1Kondo S,Kondo Y,Li G,et al.Targeted therapy of human malignant glioma in a mouse model by 2-5 A antisense directed telomerase RNA.Oncogene,1998,16(25):3323-3330.
  • 2Zamecnik PC,Stephenson ML.Inbhibition of Rous scrcoma virus replication and cell ransformation by a specific oligodeoxynucleotide.Proc Natl Acad Sci USA,1978,75(1):280.
  • 3Gurnani M,Lipari P,Dell J,et al.Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck,ovarian,prostate,and breast cancer.Cancer Chemother Pharmacol,1999,44(2):143-151.
  • 4Janicek MF,Sevin BU,Nguyen HN,et al.Combination Anti-Gene Therapy Targeting c-myc and P53 in Ovarian Cancer cell Lines.Gynecologic Oncology,1995,59:87-92.
  • 5Christoph-F,Schmidt B,Schulz WA,et al.Over-expression and amplification of the c-myc gene in human urothelial carcinoma.Int-J-Cancer.1999 Apr 20;84(2):169-173.
  • 6Droller-MJ.J-Urol.Alterations of the p53 gene in occupational bladder cancer in workers exposed to aromatic amines.1998 Aug;160(2):618.

同被引文献16

  • 1Marx J.Cell death studies yield cancer clues[J].Science,1993,259(5096):760-761.
  • 2Lowe SW,Bodis S,McClatchy A,et al.p53status and the efficacy of cancer therapy in vivo[J].Science,1994,266(5186):807-810.
  • 3Vogelstein B.Cancer.A deadly inheritance[J].Nature,1990,348(6303):681-682.
  • 4Vogelstein B,Kinzler KW.p53function and dysfunction[J].Cell,1992,70(4):523-526.
  • 5Kondo S,Kondo Y,Li G,et al.Targeted therapy of human malignant glioma in a mouse model by 2-5Aantisense directed against telomerase RNA[J].Oncogene,1998,16(25):3323-3330.
  • 6Finlay CA,Hinds PW,Levine AJ.The p53proto-oncogene can act as a suppressor of transformation[J].Cell,1989,57(7):1083-93.
  • 7Finlay CA,Hinds PW,Levine AJ.The p53proto-oncogene can act as a suppressor of transformation[J].Cell,2008,57(7):1083-1093.
  • 8Steele RJ,Thompson AM,Hall PA,et al.The p53tumor suppressor gene[J].Br J Surg,1998,85(11):1460-1467.
  • 9Eilers M,Schirm S,Bishop JM.The MYC protein activates transcription of the alpha-prothymosin gene[J].EMBO J,1991,10(1):133-141.
  • 10沈珝琲,方福德.真核基因表达调控(修订版)[M].高等教育出版社,施普林格出版社,1997:174.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部